Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:FTXHNASDAQ:IBBQNASDAQ:JDOCNASDAQ:MEDX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFTXHFirst Trust Nasdaq Pharmaceuticals ETF$26.73-2.8%$27.82$25.73▼$29.72$13.37M0.73,793 shs934 shsIBBQInvesco Nasdaq Biotechnology ETF$20.59-2.8%$22.35$20.14▼$24.84$36.44M0.6116,459 shs16,729 shsJDOCJPMorgan Healthcare Leaders ETF$52.40-1.7%$54.05$50.54▼$63.49$7.86M0.61479 shs399 shsMEDXHorizon Kinetics Medical ETF$26.77-3.2%$27.94$25.70▼$32.00$15.80M0.911,001 shs486 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFTXHFirst Trust Nasdaq Pharmaceuticals ETF-2.87%-3.27%-4.90%-0.88%-3.70%IBBQInvesco Nasdaq Biotechnology ETF-2.83%-6.49%-8.85%-4.32%-6.62%JDOCJPMorgan Healthcare Leaders ETF-1.71%-2.15%-4.22%+3.58%-9.62%MEDXHorizon Kinetics Medical ETF-3.08%-3.99%-6.36%+2.45%-9.66%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/AJDOCJPMorgan Healthcare Leaders ETFN/AN/AN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFTXHFirst Trust Nasdaq Pharmaceuticals ETF 2.63Moderate Buy$26.73N/AIBBQInvesco Nasdaq Biotechnology ETF 2.75Moderate Buy$20.59N/AJDOCJPMorgan Healthcare Leaders ETF 2.77Moderate Buy$52.40N/AMEDXHorizon Kinetics Medical ETF 2.70Moderate Buy$26.77N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/AN/AN/AN/AN/AJDOCJPMorgan Healthcare Leaders ETFN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/A21.02∞N/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/A26.48∞N/AN/AN/AN/AN/AJDOCJPMorgan Healthcare Leaders ETFN/AN/A32.12∞N/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/A27.55∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFTXHFirst Trust Nasdaq Pharmaceuticals ETF$0.481.80%N/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETF$0.241.17%N/AN/AN/AJDOCJPMorgan Healthcare Leaders ETF$2.815.36%N/AN/AN/AMEDXHorizon Kinetics Medical ETF$0.501.87%N/AN/AN/ALatest IBBQ, MEDX, FTXH, and JDOC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/26/2025FTXHFirst Trust Nasdaq Pharmaceuticals ETFQuarterly$0.09921.45%3/27/20253/27/20253/31/20253/24/2025IBBQInvesco Nasdaq Biotechnology ETF$0.04023/24/20253/24/20253/28/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AIBBQInvesco Nasdaq Biotechnology ETFN/AJDOCJPMorgan Healthcare Leaders ETFN/AMEDXHorizon Kinetics Medical ETF62.18%Insider OwnershipCompanyInsider OwnershipFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AIBBQInvesco Nasdaq Biotechnology ETFN/AJDOCJPMorgan Healthcare Leaders ETFN/AMEDXHorizon Kinetics Medical ETF4.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFTXHFirst Trust Nasdaq Pharmaceuticals ETF147,000500,000N/AOptionableIBBQInvesco Nasdaq Biotechnology ETFN/A1.77 millionN/AOptionableJDOCJPMorgan Healthcare Leaders ETFN/A150,000N/AN/AMEDXHorizon Kinetics Medical ETFN/A590,000N/ANot OptionableIBBQ, MEDX, FTXH, and JDOC HeadlinesRecent News About These CompaniesHorizon Kinetics Holding Corporation Reports Fourth Quarter and Annual ResultsMarch 26, 2025 | accessnewswire.comETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts OutlookMay 1, 2024 | zacks.comHorizon Kinetics ISE Wealth (RCH)May 13, 2023 | uk.investing.comHORIZON Fushi ChinaA 50 ETF (512150)May 11, 2023 | investing.comHorizon Kinetics Launches the Horizon Kinetics SPAC Active ETF (SPAQ) and the Horizon Kinetics Medical ETF (MEDX)April 19, 2023 | finance.yahoo.comMedia Sentiment Over TimeIBBQ, MEDX, FTXH, and JDOC Company DescriptionsFirst Trust Nasdaq Pharmaceuticals ETF NASDAQ:FTXH$26.73 -0.76 (-2.75%) Closing price 04/1/2025 03:58 PM EasternExtended Trading$26.74 +0.01 (+0.02%) As of 04/1/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.Invesco Nasdaq Biotechnology ETF NASDAQ:IBBQ$20.59 -0.60 (-2.83%) Closing price 04/1/2025 03:59 PM EasternExtended Trading$20.61 +0.02 (+0.10%) As of 04/1/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.JPMorgan Healthcare Leaders ETF NASDAQ:JDOC$52.40 -0.91 (-1.71%) As of 04/1/2025 09:37 AM EasternThe JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.Horizon Kinetics Medical ETF NASDAQ:MEDX$26.77 -0.90 (-3.25%) Closing price 04/1/2025 03:51 PM EasternExtended Trading$26.77 0.00 (0.00%) As of 04/1/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy Amazon Falls Back to a Key Support Line: Here's How to Play It Berkshire Hathaway Gains Defy Stock Market Slump Tech Sell-Off Makes Microsoft Stock Look Like a Steal Palantir Stock Builds Momentum on New Partnership Amprius Market Gets Amped Up on Growth Outlook 3 Buyable Stocks With Solid Bottoms Ready to Rebound Game-Changing News for Advanced Micro Devices Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
